Clinical Trial Update: BCD Regimen in Newly Diagnosed Idiopathic Multicentric Castleman's Disease (iMCD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for the BCD regimen in newly diagnosed idiopathic multicentric Castleman's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Multicentric Castleman Disease

Drugs mentioned

• BCD regimen

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Idiopathic Multicentric Castleman's Disease | Phase 2 | Status: UNKNOWN